Toxicity Testing of Natural Products

Toxicity testing of natural products is the systematic assessment of the capacity of plant extracts, isolated phytochemicals, and other natural materials to cause harm to living systems. It applies the standard toolkit of toxicology — in vitro assays, in vivo studies, and dose-response analysis — to materials whose chemical complexity and variability make their hazards harder to characterise than those of single synthetic compounds.

Definition

Toxicity testing of natural products is the experimental evaluation, using in vitro and in vivo methods and dose-response analysis, of the adverse biological effects of plant-derived and other natural materials.

Scope

The topic covers the tiers of toxicity assessment commonly applied to botanicals: in vitro cytotoxicity and genotoxicity screens, acute and repeated-dose in vivo studies, and endpoint-specific testing such as hepatotoxicity and genotoxicity. It addresses why natural products pose particular testing challenges — complex mixtures, batch-to-batch variation, and active constituents that require metabolic bioactivation — and how standardised protocols aim to make results comparable. It is a reference-educational account of testing methods, not a protocol for clinical use.

Core questions

• What in vitro and in vivo methods are used to screen natural products for toxicity, and what does each detect?
• How does the chemical complexity and variability of botanical mixtures complicate toxicity assessment?
• How are dose-response data used to derive measures such as the median lethal dose or no-observed-adverse-effect level?
• Which endpoints — for example hepatotoxicity, genotoxicity, and bioactivation of constituents — are especially relevant to natural products?

Key concepts

• Dose-response relationship
• Acute versus repeated-dose toxicity
• In vitro cytotoxicity and genotoxicity assays
• Median lethal dose and no-observed-adverse-effect level
• Metabolic bioactivation
• Hepatotoxicity as a key endpoint
• Standardised testing protocols

Mechanisms

Toxicity testing proceeds in tiers. In vitro assays on cultured cells screen for cytotoxicity, while bacterial and mammalian-cell tests probe genotoxicity and mutagenicity. In vivo studies expose animals to graded doses to establish a dose-response curve, from acute single-dose protocols that estimate measures such as the median lethal dose to repeated-dose studies that identify the no-observed-adverse-effect level and target organs. A recurring feature of natural products is that some constituents are not themselves toxic until metabolically bioactivated — pyrrolizidine alkaloids, for instance, are converted in the liver to reactive pyrrole esters — so testing must account for metabolism, and the liver is a frequent target organ.

Clinical relevance

Toxicity-testing data underpin safety judgements about botanical ingredients and help explain documented harms such as herbal hepatotoxicity. This topic describes how such evidence is generated; it does not provide thresholds for individual use, which fall outside reference-educational scope.

Evidence & guidelines

Standardised testing follows internationally harmonised protocols, including the OECD Guidelines for the Testing of Chemicals, which specify methods such as the up-and-down procedure for acute oral toxicity. The World Health Organization provides complementary guidance on safety assessment and monitoring of herbal medicines. Reviews of herbal hepatotoxicity and of pyrrolizidine-alkaloid toxicity illustrate how testing endpoints map onto real-world hazards.

History

Toxicity testing of plant materials grew out of classical toxicology, which from the early twentieth century formalised dose-response analysis and standardised animal testing. As botanicals became mass-market products, internationally harmonised protocols such as the OECD test guidelines were adapted to assess them, and growing reports of harms like herbal hepatotoxicity sharpened attention on endpoints relevant to complex natural mixtures.

Debates

How well do standard single-compound testing paradigms fit complex botanical mixtures?

Protocols developed for defined chemicals must contend with the variability and multi-constituent nature of plant extracts, and there is ongoing discussion about how to test whole preparations versus isolated marker compounds.

Key figures

• Felix Stickel
• Peter P. Fu

Seminal works

• oecd-425-2022
• stickel-2015
• fu-2020-pa

Frequently asked questions

Why are natural products harder to test for toxicity than single drugs?

They are complex, variable mixtures whose composition can differ between batches, and some constituents become toxic only after metabolic activation, so a single assay rarely captures the full hazard.

What is dose-response analysis?

It is the study of how a biological effect changes with the dose of a substance, used to derive measures such as the median lethal dose and the no-observed-adverse-effect level.